Phibro Animal Health Cost of Goods Sold 2012-2024 | PAHC

Phibro Animal Health cost of goods sold from 2012 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Phibro Animal Health Annual Cost of Goods Sold
(Millions of US $)
2024 $705
2023 $680
2022 $657
2021 $562
2020 $543
2019 $563
2018 $553
2017 $516
2016 $512
2015 $515
2014 $488
2013 $474
2012 $490
2011 $472
Phibro Animal Health Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $177
2024-06-30 $186
2024-03-31 $184
2023-12-31 $171
2023-09-30 $164
2023-06-30 $178
2023-03-31 $170
2022-12-31 $167
2022-09-30 $164
2022-06-30 $177
2022-03-31 $168
2021-12-31 $162
2021-09-30 $150
2021-06-30 $150
2021-03-31 $143
2020-12-31 $138
2020-09-30 $131
2020-06-30 $125
2020-03-31 $141
2019-12-31 $145
2019-09-30 $132
2019-06-30 $139
2019-03-31 $141
2018-12-31 $150
2018-09-30 $134
2018-06-30 $144
2018-03-31 $140
2017-12-31 $139
2017-09-30 $130
2017-06-30 $132
2017-03-31 $129
2016-12-31 $128
2016-09-30 $127
2016-06-30 $130
2016-03-31 $125
2015-12-31 $130
2015-09-30 $128
2015-06-30 $127
2015-03-31 $128
2014-12-31 $133
2014-09-30 $127
2014-06-30 $133
2014-03-31 $120
2013-12-31 $122
2013-09-30 $113
2013-06-30
2013-03-31 $117
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.962B $1.018B
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.249B 26.05
Stryker (SYK) United States $146.711B 33.06
Boston Scientific (BSX) United States $132.644B 38.14
EssilorLuxottica (ESLOY) France $112.106B 0.00
Medtronic (MDT) Ireland $110.562B 16.42
Haleon (HLN) United Kingdom $43.682B 28.38
Lonza Group Ag (LZAGY) Switzerland $42.166B 0.00
GE HealthCare Technologies (GEHC) United States $37.665B 19.54
ResMed (RMD) United States $35.786B 29.41
Terumo (TRUMY) Japan $29.739B 0.00
Koninklijke Philips (PHG) Netherlands $24.805B 18.99
Zimmer Biomet Holdings (ZBH) United States $21.942B 13.97
Insulet (PODD) United States $18.443B 73.44
Baxter (BAX) United States $16.957B 11.03
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.158B 40.72
Bio-Rad Laboratories (BIO) United States $9.320B 31.68
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.294B 14.62
TG Therapeutics (TGTX) United States $5.459B 0.00
Haemonetics (HAE) United States $4.297B 20.97
Prestige Consumer Healthcare (PBH) United States $4.192B 20.85
ICU Medical (ICUI) United States $4.125B 39.27
Perrigo (PRGO) Ireland $3.830B 11.27
Envista Holdings (NVST) United States $3.697B 27.54
Neogen (NEOG) United States $3.246B 37.45
Agios Pharmaceuticals (AGIO) United States $3.175B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.841B 18.22
QuidelOrtho (QDEL) United States $2.700B 17.38
LeMaitre Vascular (LMAT) United States $2.428B 59.00
Warby Parker (WRBY) United States $2.349B 0.00
Green Thumb Industries (GTBIF) United States $1.913B 33.48
AtriCure (ATRC) United States $1.742B 0.00
InMode (INMD) Israel $1.597B 9.61
AdaptHealth (AHCO) United States $1.326B 9.48
Maravai LifeSciences Holdings (MRVI) United States $1.318B 0.00
Curaleaf Holdings (CURLF) Canada $1.267B 0.00
BioLife Solutions (BLFS) United States $1.207B 0.00
Owens & Minor (OMI) United States $0.952B 7.44
CeriBell (CBLL) United States $0.943B 0.00
National Vision Holdings (EYE) United States $0.918B 30.68
Capricor Therapeutics (CAPR) United States $0.847B 0.00
Evolus (EOLS) United States $0.798B 0.00
VAREX IMAGING (VREX) United States $0.684B 30.25
Omeros (OMER) United States $0.632B 0.00
Surmodics (SRDX) United States $0.563B 0.00
Cresco Labs (CRLBF) United States $0.533B 0.00
Verano Holdings (VRNOF) United States $0.522B 0.00
Canopy Growth (CGC) Canada $0.468B 0.00
Quanterix (QTRX) United States $0.451B 0.00
ZimVie (ZIMV) United States $0.391B 32.95
Valneva SE (VALN) France $0.360B 0.00
Viemed Healthcare (VMD) United States $0.341B 32.41
Cerus (CERS) United States $0.332B 0.00
Sanara MedTech (SMTI) United States $0.330B 0.00
Biote (BTMD) United States $0.325B 7.12
OraSure Technologies (OSUR) United States $0.289B 19.40
Zynex (ZYXI) United States $0.263B 55.07
Aurora Cannabis (ACB) Canada $0.238B 0.00
TerrAscend (TSNDF) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.221B 15.29
High Tide (HITI) Canada $0.213B 88.33
MacroGenics (MGNX) United States $0.203B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.167B 100.00
Organigram Holdings (OGI) Canada $0.166B 0.00
Jin Medical (ZJYL) China $0.164B 0.00
Zevia PBC (ZVIA) United States $0.160B 0.00
FitLife Brands (FTLF) United States $0.149B 18.67
TriSalus Life Sciences (TLSI) United States $0.138B 0.00
Fonar (FONR) United States $0.104B 11.74
Quipt Home Medical (QIPT) United States $0.104B 0.00
Veru (VERU) United States $0.099B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.40
Ayr Wellness (AYRWF) United States $0.077B 0.00
Rockwell Medical (RMTI) United States $0.073B 37.50
Exagen (XGN) United States $0.072B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.062B 0.00
Modular Medical (MODD) United States $0.058B 0.00
MariMed (MRMD) United States $0.057B 0.00
Apyx Medical (APYX) United States $0.054B 0.00
Safety Shot (SHOT) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
Meihua Medical Technologies (MHUA) China $0.018B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00